Andromeda increases the efficiency of Biopharma and CROs protein production teams by optimizing expression conditions and offering knowledge of expression levels and thermal stability from a single assay before protein purification.
Have a question about Andromeda?
Contact SpecialistSee more related content
32:05Poor expression levels, solubilization, and stability — these are the daily challenges that your membrane protein production team faces every day. You go through long cycles of expression optimization
12:06What you’ll learn It’s very common to experience low expression levels when producing membrane proteins — plus they’re finicky and unstable when they're outside of their native environment. Just know
NanoTemper launches Andromeda, helping Biopharma and CROs to increase efficiency of expression screening for membrane proteins
SOUTH SAN FRANCISCO, Calif. June 24, 2021 — NanoTemper Technologies, well-known for creating biophysical tools that tackle challenging characterizations, enters the protein production market with...